Gene · 9388
Papers1,360
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,360
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study. | Am J Kidney Dis | 2026 | 42772348 | PubTator, text mining | PubMed |
| Association of ABCA1 and LIPG Polymorphisms with Coronary Heart Disease in a Chinese Han Population: A Case-Control Study with Sex-Stratified Analysis. | Int J Gen Med | 2026 | 42553736 | PubTator, text mining | PubMed |
| An Integrated Multi-omics Single Cell Atlas of the Human RPE and Choroid. | bioRxiv | 2026 | 42539169 | PubTator, text mining | PubMed |
| Single-blastomere transcriptomics identifies NR5A2-associated metabolic genes during porcine zygotic genome activation. | Theriogenology | 2026 | 42497609 | PubTator, text mining | PubMed |
| Size-Resolved Lipoprotein Fatty Acid Content as a Novel Nuclear Magnetic Resonance-Derived Trait Specifically Associates with Genetic Variants That Control Fatty Acid Metabolism. | J Proteome Res | 2026 | 42365607 | PubTator, text mining | PubMed |
| Integrated metabolomic and transcriptomic analysis identifies enhanced phosphatidylcholine metabolism in placenta accreta spectrum. | BMC Pregnancy Childbirth | 2026 | 42337473 | PubTator, text mining | PubMed |
| Immunogenetic modulation of endothelial inflammation by the LIPG -384A/C promoter variant influences COVID-19 severity. | Front Immunol | 2026 | 42317324 | PubTator, text mining | PubMed |
| Endothelial Lipase RS3744843 Polymorphism and Lipid Profile in Bechet's Disease Patients. | Tunis Med | 2026 | 42246713 | PubTator, text mining | PubMed |
| Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study. | Cardiovasc Diabetol | 2026 | 42135799 | PubTator, text mining | PubMed |
| Altered small dense LDL profiles in long-standing controlled type 1 diabetes. | Front Endocrinol (Lausanne) | 2026 | 42022901 | PubTator, text mining | PubMed |
| Genealogy-based trait association with LOCATER boosts power at loci with allelic heterogeneity. | Genome Res | 2026 | 41991327 | PubTator, text mining | PubMed |
| NCBP2 drives colorectal cancer growth and metastasis through LIPG-mediated lipid droplet accumulation. | Commun Biol | 2026 | 41872454 | PubTator, text mining | PubMed |
| Post-heparin plasma lipase activities in patients with severe hypertriglyceridemia treated with evinacumab. | J Lipid Res | 2026 | 41831525 | PubTator, text mining | PubMed |
| Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome. | Circ Rep | 2026 | 41808948 | PubTator, text mining | PubMed |
| A Narrative Review of Remnant Cholesterol as an Independent Atherogenic Lipoprotein in Type 2 Diabetes: Pathophysiology and Clinical Implications. | Ther Clin Risk Manag | 2026 | 41799835 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia. | Signal Transduct Target Ther | 2026 | 41775694 | PubTator, text mining | PubMed |
| ApoJ regulates endothelial lipase activity and stability. | Protein Sci | 2026 | 41772802 | PubTator, text mining | PubMed |
| Lipoprotein Metabolism in Hematological Malignancies: A Role in Shaping the Tumor Cell Microenvironment? | Metabolites | 2026 | 41745626 | PubTator, text mining | PubMed |
| Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes. | Clin Med Insights Endocrinol Diabetes | 2026 | 41743491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9388/papers